# C. Martin Bunke

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/c-martin-bunke/

## Facts

| Field | Value |
| --- | --- |
| Citations | 430 |
| Field | Renal Transplantation Outcomes and Treatments |
| h-index | 8 |
| i10-index | 7 |
| OpenAlex ID | https://openalex.org/A5084434137 |
| Works | 23 |

## Researcher papers

- [Outcomes of single organism peritonitis in peritoneal dialysis: Gram negatives versus gram positives in the Network 9 Peritonitis Study](https://scholariq.org/papers/outcomes-of-single-organism-peritonitis-in-peritoneal-dialysis-gram-negatives/)
- [Vancomycin kinetics during continuous ambulatory peritoneal dialysis](https://scholariq.org/papers/vancomycin-kinetics-during-continuous-ambulatory-peritoneal-dialysis/)
- [Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis](https://scholariq.org/papers/cefazolin-and-cephalexin-kinetics-in-continuous-ambulatory-peritoneal-dialysis/)
- [THE SAFETY AND TOLERABILITY OF CYCLOSPORINE EMULSION VERSUS CYCLOSPORINE IN A RANDOMIZED, DOUBLE-BLIND COMPARISON IN PRIMARY RENAL ALLOGRAFT RECIPIENTS1](https://scholariq.org/papers/the-safety-and-tolerability-of-cyclosporine-emulsion-versus-cyclosporine-in-a/)
- [Pharmacokinetics of Common Antibiotics Used in Continuous Ambulatory Peritoneal Dialysis](https://scholariq.org/papers/pharmacokinetics-of-common-antibiotics-used-in-continuous-ambulatory-peritoneal/)
- [Erythropoietin-induced antinatriuresis mediated by angiotensin II in perfused kidneys.](https://scholariq.org/papers/erythropoietin-induced-antinatriuresis-mediated-by-angiotensin-ii-in-perfused/)
- [Mezlocillin kinetics in hepatic insufficiency](https://scholariq.org/papers/mezlocillin-kinetics-in-hepatic-insufficiency/)
- [USE OF OKT3 MONOCLONAL ANTIBODY IN THE TREATMENT OF ACUTE CARDIAC ALLOGRAFT REJECTION](https://scholariq.org/papers/use-of-okt3-monoclonal-antibody-in-the-treatment-of-acute-cardiac-allograft/)
- [Safety and tolerability of neoral vs sandimmune: 1-year data in primary renal allograft recipients](https://scholariq.org/papers/safety-and-tolerability-of-neoral-vs-sandimmune-1-year-data-in-primary-renal/)
- [Kidney Failure Attributed to Focal Segmental Glomerulosclerosis: A USRDS Retrospective Cohort Study of Epidemiology, Treatment Modalities, and Economic Burden](https://scholariq.org/papers/kidney-failure-attributed-to-focal-segmental-glomerulosclerosis-a-usrds/)

## Researcher topics

- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.